ClinConnect ClinConnect Logo
Search / Trial NCT06243926

Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate

Launched by CREA MEDICINA DE LA REPRODUCCIÓN SL · Feb 5, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Icsi Sperm Selection Microfluidics Assisted Reproduction Techniques

ClinConnect Summary

This clinical trial is studying a new way to select sperm for a procedure called Intracytoplasmic Sperm Injection (ICSI), which is used to help people achieve pregnancy. The researchers are comparing two methods: the traditional technique called Density-Gradient Centrifugation (DGC) and a new handmade approach that uses special fluid walls to guide sperm movement based on their natural swimming behavior. The goal is to see which method better selects the best sperm to improve the chances of a successful ICSI procedure.

To participate in this trial, you need to be a female under 40 years old undergoing ICSI, have at least 6 mature eggs retrieved, and a male partner under 50 with at least 1 million moving sperm. This trial is currently recruiting participants, and it's important to note that it excludes those using surgically retrieved or frozen eggs and sperm. If you join, you can expect to contribute to important research that may improve fertility treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing ICSI
  • Female age under 40 years old
  • Number of mature oocytes (MII) upon oocyte retrieval ≥ 6
  • Male age under 50 years old
  • Total number of progressive sperm ≥ 1 million
  • Exclusion Criteria:
  • Patients with surgically retrieved sperm for ICSI
  • Cases using cryopreserved oocytes
  • Cases using cryopreserved sperm

About Crea Medicina De La Reproducción Sl

Crea Medicina de la Reproducción SL is a leading clinical trial sponsor specializing in reproductive medicine. With a commitment to advancing the field through innovative research and development, Crea collaborates with healthcare professionals and institutions to conduct rigorous clinical trials aimed at improving fertility treatments and outcomes. The organization is dedicated to enhancing patient care through evidence-based practices, leveraging cutting-edge technologies, and fostering a multidisciplinary approach to reproductive health. Crea's expertise and dedication position it as a pivotal player in the advancement of reproductive medicine.

Locations

Valencia, , Spain

Patients applied

0 patients applied

Trial Officials

Miguel Ruiz-Jorro MD, MSc, PhD

Principal Investigator

CREA. Medicina de la Reproducción S.L.

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported